Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer
Clinical trial NCT03647969 · COMPLETED
Trial details
- NCT number
- NCT03647969
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-07
- Primary completion
- 2024-07-19
- Enrollment
- 262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.